Biotech investors in the United Kingdom
Updated 16 Nov 2026
Venture funds
9 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Innovate UK Innovate UK runs funding competitions for businesses and research organizations in emerging technologies, with recent awardees including Ryft and Concretene. Swindon, United Kingdom |
Artificial intelligence, Health care | 75% | 8 | |
| 2 | Cambridge Innovation Capital Cambridge Innovation Capital invests in early-stage deep technology and life sciences companies, including T-Therapeutics and Microbiotica. Cambridge, United Kingdom |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 36% | 2 |
| 3 | Dementia Discovery Fund Dementia Discovery Fund invests exclusively in novel dementia therapeutics, with recent investments in Alchemab Therapeutics and Cerevance. London, United Kingdom |
Biotech, Health care | Seed, Early stage venture | 42% | 2 |
| 4 | Exceptional Ventures Exceptional Ventures focuses on early-stage entrepreneurs and businesses that improve people's lives, and recently backed Sava Technology and Amatera. London, United Kingdom |
Health care, Biotech | Seed, Early stage venture | 8% | 2 |
| 5 | Future Planet Capital London, United Kingdom |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 3% | 2 |
| 6 | Medicxi Medicxi focuses on life sciences, with recent companies Vaderis Therapeutics and D3 Bio. London, United Kingdom |
Biotech, Health care | Seed, Early stage venture | 54% | 2 |
| 7 | Octopus Ventures Octopus Ventures supports companies from idea conception to IPO, including Living Optics and Edgify. London, United Kingdom |
Artificial intelligence, Health care | Seed, Early stage venture, Late stage venture | 54% | 2 |
| 8 | SoftBank Vision Fund SoftBank Vision Fund makes growth capital and social impact investments, with recent companies including WHOOP and Opentrons. London, United Kingdom |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 71% | 2 |
| 9 | XTX Ventures XTX Ventures invests in startups applying machine learning, recently backing CloudNC and Qureight. London, United Kingdom |
Artificial intelligence, Health care | Seed, Early stage venture | 22% | 2 |
Table 1. Biotech investors in the United Kingdom: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Innovate UK | Entrepreneurship program | Swindon, United Kingdom | •••@innovateuk.ukri.org | |
| Octopus Ventures | Venture capital firm | London, United Kingdom | •••@octopusvnetures.com | +44 20••• |
| SFC Capital | Angel group | Northwich, United Kingdom | •••@sfccapital.com | +44 20••• |
| Scottish Enterprise | Government investment office | Glasgow, United Kingdom | •••@scotent.co.uk | +03000••• |
| Future Planet Capital | Venture capital firm | London, United Kingdom | •••@futureplanetcapital.com | +44 79••• |
| Oxford Science Enterprises | Venture capital firm | Oxford, United Kingdom | •••@oxfordsciences.com | 01865 ••• |
| Marshall Wace | Hedge fund | London, United Kingdom | •••@mwam.com | 212 23••• |
| Medicxi | Venture capital firm | London, United Kingdom | •••@medicxi.com | +44 20••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 50 of the 68 biotech investors in the United Kingdom have a published email address, 44 a phone number and 68 a website.
- Innovate UK has the most recorded investments, 1,307, 976 of them as lead investor.
- 50 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Innovate UK is an investor in 27 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is T-Therapeutics' $133.0M Series B on 5 November 2026.
- Software is the most common sector across their 1,948 portfolio companies (76%).
- Early stage venture is the most common investment stage, recorded for 59 of them (87%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors in the United Kingdom
30 of 68, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Innovate UK | Entrepreneurship program, Venture capital firm | Swindon, United Kingdom | Artificial intelligence, Health care | Bioliberty, Concretene, Doctoria LTD | 27 | 1,307 | 976 | 84 | •••@innovateuk.ukri.org | In the CSV | |
| 2 | Octopus Ventures | Venture capital firm | London, United Kingdom | Artificial intelligence, Health care | Living Optics, Metris Energy, Edgify | 9 | 477 | 259 | 73 | •••@octopusvnetures.com | +44 20••• | In the CSV |
| 3 | SFC Capital | Angel group, Micro VC fund | Northwich, United Kingdom | Fintech, Artificial intelligence | OSSTEC, Alchera Technologies, Ryft | 11 | 768 | 267 | 23 | •••@sfccapital.com | +44 20••• | In the CSV |
| 4 | Scottish Enterprise | Government investment office | Glasgow, United Kingdom | Health care, Hardware | Bioliberty, Danu Robotics, Mironid | 6 | 392 | 140 | 36 | •••@scotent.co.uk | +03000••• | In the CSV |
| 5 | Future Planet Capital | Venture capital firm | London, United Kingdom | Biotech, Health care | Luffy AI, Captura, CellCentric | 4 | 360 | 12 | 27 | •••@futureplanetcapital.com | +44 79••• | In the CSV |
| 6 | Oxford Science Enterprises | Venture capital firm | Oxford, United Kingdom | Health care, Artificial intelligence | Fractile, Quantrol Ox, Salience Labs | 7 | 186 | 76 | 15 | •••@oxfordsciences.com | 01865 ••• | In the CSV |
| 7 | Eight Roads Ventures | Venture capital firm | London, United Kingdom | Fintech, Health care | Kaiko, Sonosemi Medical, Exponent Energy | 8 | 552 | 236 | 134 | +91 80••• | In the CSV | |
| 8 | SoftBank Vision Fund | Private equity firm, Venture capital firm | London, United Kingdom | Artificial intelligence, Hardware | Opentrons, WHOOP, Early Health | 4 | 471 | 334 | 91 | +44 02••• | In the CSV | |
| 9 | Marshall Wace | Hedge fund | London, United Kingdom | Biotech, Health care | TRM Labs | 1 | 80 | 18 | 38 | •••@mwam.com | 212 23••• | In the CSV |
| 10 | Medicxi | Venture capital firm | London, United Kingdom | Biotech, Health care | Vaderis Therapeutics, D3 Bio | 2 | 59 | 32 | 16 | •••@medicxi.com | +44 20••• | In the CSV |
| 11 | IP Group | Venture capital firm | London, United Kingdom | Hardware, Artificial intelligence | Microbiotica, Oxford Quantum Circuits, Oxa | 3 | 304 | 59 | 38 | •••@ipgroupplc.com | +44 (0••• | In the CSV |
| 12 | Eos | Venture capital firm | Saint Andrews, United Kingdom | Health care, Biotech | Bioliberty, Neupulse | 2 | 35 | 19 | 0 | •••@eos-advisory.com | In the CSV | |
| 13 | Parkwalk Advisors | Venture capital firm | London, United Kingdom | Hardware, Artificial intelligence | OSSTEC, Adsilico, Reclinker | 10 | 339 | 91 | 32 | •••@parkwalkadvisors.com | +44 20••• | In the CSV |
| 14 | Janus Henderson Investors | Private equity firm, Venture capital firm | London, United Kingdom | Health care, Biotech | Claris Biotherapeutics | 1 | 240 | 34 | 144 | •••@janushenderson.com | +44 (0••• | In the CSV |
| 15 | Abingworth | Private equity firm, Venture capital firm | London, United Kingdom | Biotech, Health care | Timberlyne Therapeutics, Myricx Bio, Anjarium Biosciences | 196 | 56 | 90 | •••@abingworth.com | (207) ••• | In the CSV | |
| 16 | IQ Capital | Venture capital firm | London, United Kingdom | Artificial intelligence, Cybersecurity | Mindgard, Quantum Diamonds, RevEng | 4 | 183 | 60 | 20 | •••@iqcapital.vc | +44 (0••• | In the CSV |
| 17 | RebelBio | Startup accelerator | London, United Kingdom | Biotech, Health care | VisusNano, Rize Health, Helixworks | 120 | 0 | 2 | In the CSV | |||
| 18 | Kindred Capital | Venture capital firm | London, United Kingdom | Artificial intelligence, Hardware | Fractile, Dexory, Infinitopes | 3 | 108 | 33 | 12 | •••@kindredcapital.vc | +44 75••• | In the CSV |
| 19 | Old College Capital | University program, Venture capital firm | Edinburgh, United Kingdom | Health care, Biotech | Bioliberty, Aveni, Exergy3 | 3 | 85 | 3 | 2 | 0131 4••• | In the CSV | |
| 20 | MVM Life Science Partners | Venture capital firm | London, United Kingdom | Health care, Biotech | GT Medical Technologies, SkyCell, Xention | 76 | 34 | 28 | •••@mvm.com | +44 (0••• | In the CSV | |
| 21 | Creator Fund | Venture capital firm | London, United Kingdom | Artificial intelligence, Health care | Malted AI, Quantum Diamonds, Helical | 6 | 68 | 27 | 3 | •••@thecreatorfund.com | In the CSV | |
| 22 | TRICAPITAL | Startup accelerator, Angel group | Melrose, United Kingdom | Biotech, Health care | ŌGI Bio, Glen Clova Scientific, Carcinotech | 64 | 21 | 4 | •••@tricapital.co.uk | +44 18••• | In the CSV | |
| 23 | Balderton Capital | Venture capital firm | London, United Kingdom | Fintech, Artificial intelligence | Sava Technology, TILT, Primer | 7 | 477 | 216 | 98 | •••@balderton.com | +44 (0••• | In the CSV |
| 24 | 3i Group | Private equity firm, Venture capital firm | London, United Kingdom | Hardware, Health care | Twenga, Endosense, OmniGuide | 476 | 140 | 195 | •••@3i.com | 44 (0)••• | In the CSV | |
| 25 | Amadeus Capital Partners | Venture capital firm | Cambridge, United Kingdom | Artificial intelligence, Hardware | iPronics, Tenzo, Refute | 5 | 293 | 86 | 64 | •••@amadeuscapital.com | +44 33••• | In the CSV |
| 26 | Maven Capital Partners | Private equity firm, Venture capital firm | Glasgow, United Kingdom | Artificial intelligence, Hardware | Connected Data, Novatus Global, RwHealth | 225 | 162 | 39 | •••@mavencp.com | 0141 3••• | In the CSV | |
| 27 | Baillie Gifford | Private equity firm | Edinburgh, United Kingdom | Biotech, Health care | TEKEVER, Cosm | 2 | 215 | 53 | 55 | •••@bailliegifford.com | 44 (0)••• | In the CSV |
| 28 | Tiny Supercomputer Investment Company | Venture capital firm | London, United Kingdom | Artificial intelligence, Hardware | Zero, Neuphonic, bunch | 8 | 174 | 2 | 21 | In the CSV | ||
| 29 | UK Innovation & Science Seed Fund | Venture capital firm | Harwell, United Kingdom | Biotech, Health care | Lineat Composites, ExactTrak, HutanBio | 139 | 47 | 8 | •••@uki2s.co.uk | 0121 7••• | In the CSV | |
| 30 | Praetura Ventures | Venture capital firm | Manchester, United Kingdom | Artificial intelligence, Health care | Covatic, EarSwitch | 2 | 122 | 93 | 9 | •••@praetura.co.uk | 0161 6••• | In the CSV |
Table 2. Biotech investors in the United Kingdom: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 68.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Innovate UK | Swindon, United Kingdom | 27 | 163 | Bioliberty, Concretene, Doctoria LTD |
| 2 | Seedcamp | London, United Kingdom | 15 | 203 | Metaview, Flow Engineering, Rayon |
| 3 | SFC Capital | Northwich, United Kingdom | 11 | 185 | OSSTEC, Alchera Technologies, Ryft |
| 4 | Parkwalk Advisors | London, United Kingdom | 10 | 38 | OSSTEC, Adsilico, Reclinker |
| 5 | Octopus Ventures | London, United Kingdom | 9 | 122 | Living Optics, Metris Energy, Edgify |
| 6 | Tiny Supercomputer Investment Company | London, United Kingdom | 8 | 64 | Zero, Neuphonic, bunch |
| 7 | Eight Roads Ventures | London, United Kingdom | 8 | 106 | Kaiko, Sonosemi Medical, Exponent Energy |
| 8 | Oxford Science Enterprises | Oxford, United Kingdom | 7 | 25 | Fractile, Quantrol Ox, Salience Labs |
| 9 | Balderton Capital | London, United Kingdom | 7 | 80 | Sava Technology, TILT, Primer |
| 10 | Scottish Enterprise | Glasgow, United Kingdom | 6 | 44 | Bioliberty, Danu Robotics, Mironid |
| 11 | Northzone | London, United Kingdom | 6 | 60 | Rayon, Tandem Health, Monumental |
| 12 | Creator Fund | London, United Kingdom | 6 | 17 | Malted AI, Quantum Diamonds, Helical |
| 13 | Amadeus Capital Partners | Cambridge, United Kingdom | 5 | 36 | iPronics, Tenzo, Refute |
| 14 | SoftBank Vision Fund | London, United Kingdom | 4 | 71 | Opentrons, WHOOP, Early Health |
| 15 | XTX Ventures | London, United Kingdom | 4 | 24 | CloudNC, Qureight, Lucida Medical |
Table 3. Biotech investors in the United Kingdom: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | Cambridge Innovation Capital, University of Cambridge Enterprise | 51 to 100 | 2022 |
| Takenos | Takenos offers a digital wallet that lets users receive, send, manage, and spend international money. | Fintech | Buenos Aires, Argentina | Seed | $7.0M | 2026-11-04 | $12.2M | Outlier Ventures | 11 to 50 | 2022 |
| OSSTEC | OSSTEC develops products for orthopaedic treatment. | Hardware | London, United Kingdom | Series A | $8.0M | 2026-11-03 | $12.7M | SFC Capital, Parkwalk Advisors | 11 to 50 | 2021 |
| Bioliberty | Bioliberty develops rehabilitation solutions for degenerative and traumatic conditions as a medtech start-up. | Biotech | Edinburgh, United Kingdom | Series A | $3.3M | 2026-11-02 | $17.4M | Innovate UK, Eos, Scottish Enterprise +1 | 11 to 50 | 2020 |
| Fractile | Fractile develops semiconductor hardware and AI inference systems for large language model processing. | Artificial intelligence | London, United Kingdom | Series C | $771.2M | 2026-10-29 | $1.0B | Oxford Science Enterprises, Kindred Capital | 101 to 250 | 2022 |
| Opentrons Unicorn | Opentrons develops pipetting robots that automate laboratory experiments in the life sciences. | Artificial intelligence | Long Island City, United States | Series E | $40.0M | 2026-10-29 | $300.2M | SoftBank Vision Fund | 251 to 500 | 2014 |
| Onego Bio | Onego Bio produces egg protein through fermentation as a food ingredient. | Biotech | Helsinki, Finland | Series B | $28.0M | 2026-10-26 | $100.6M | NordicNinja VC | 11 to 50 | 2022 |
| Adsilico | Adsilico develops new approaches to medical device innovation. | Health care | Leeds, United Kingdom | Series A | $13.3M | 2026-10-26 | $17.8M | Parkwalk Advisors, Northern Gritstone | 1 to 10 | 2022 |
| Quantrol Ox | QuantrolOx builds machine learning control software that tunes and stabilizes qubits for quantum technologies. | Artificial intelligence | Espoo, Finland | Series A | $13.5M | 2026-10-22 | $21.5M | Oxford Science Enterprises | 11 to 50 | 2021 |
| Microbiotica | Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. | Biotech | Cambridge, United Kingdom | Series C | $47.9M | 2026-10-16 | $130.7M | IP Group, Cambridge Innovation Capital, British Patient Capital | 11 to 50 | 2016 |
Table 4. Biotech investors in the United Kingdom: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 1,474 | 76% |
| Artificial intelligence | 469 | 24% |
| Fintech | 449 | 23% |
| Hardware | 302 | 16% |
| Health care | 288 | 15% |
| Biotech | 181 | 9% |
| Commerce | 171 | 9% |
| Education | 90 | 5% |
| Cybersecurity | 81 | 4% |
| Energy | 50 | 3% |
Table 5. Biotech investors in the United Kingdom: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 59 | 87% |
| Seed investors | 56 | 82% |
| Venture investors | 36 | 53% |
| Late stage investors | 27 | 40% |
| Private equity investors | 11 | 16% |
| Debt investors | 6 | 9% |
| Convertible note investors | 6 | 9% |
| Grant makers | 5 | 7% |
Table 6. Biotech investors in the United Kingdom by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Biotech investors in the United Kingdom by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 8 | 12% |
| 2010s | 30 | 45% |
| 2000s | 15 | 22% |
| 1990s | 6 | 9% |
| 1980s | 2 | 3% |
| 1970s | 1 | 1% |
Table 8. Biotech investors in the United Kingdom by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies and its headquarters is in the United Kingdom. On 16 November 2026 that is 68 investors.
- 50 rows carry an email address and 44 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 68 rows: 0 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors in the United Kingdom are on the list?
- 68, in the file dated 16 November 2026. 50 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 50 of the 68 carry an email address in the download and 44 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 68 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 68 rows, 50 firm email addresses and 44 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 43 of the 50 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.